Showing results (441-450 of 498) with videos related to
Sort By:
Pageof 50
JAMA|March 30, 2007
Contemporary clinical profile and outcome of prosthetic valve endocarditisAndrew Wang, Eugene Athan, Paul A Pappas, et al.Circulation. Cardiovascular Imaging|November 6, 2022
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.Journal of the American College of Cardiology|April 3, 2012
Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trialHoward C Herrmann, Zachary M Gertz, Frank E Silvestry, et al.Hepatology (Baltimore, Md.)|April 22, 2025
Long-term mortality and extrahepatic outcomes in 1096 children with MASLD: A retrospective cohort studyJeffrey B Schwimmer, Nhat Quang N Thai, Sheila L Noon, et al.BMC Cardiovascular Disorders|July 29, 2022
Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality-a nationwide studyAndreas Dalsgaard Jensen, Lauge Østergaard, Jeppe K Petersen, et al.American Heart Journal|February 26, 2019
Association between the timing of surgery for complicated, left-sided infective endocarditis and survivalAndrew Wang, Vivian H Chu, Eugene Athan, et al.Circulation. Cardiovascular Imaging|September 2, 2024
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM TrialMilind Y Desai, Yuichiro Okushi, Andrew Gaballa, et al.JACC. Cardiovascular Imaging|September 16, 2025
Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks: Insights From the VALOR-HCM TrialMilind Y Desai, Yuichiro Okushi, Kathy Wolski, et al.European Heart Journal|September 1, 2024
Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathyPablo Garcia-Pavia, Artur Oręziak, Ahmad Masri, et al.Urologic Oncology|July 1, 2015
Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settingsTracy L Rose, Allison M Deal, Ethan Basch, et al.Pageof 50